EODData

MEMBERSHIP REGISTER LOG IN

FRA, PBDA: PROTALIX BIOTHERAP.DL-01

03 Sep 2026
LAST:

2.205

CHANGE:
 0.01		OPEN:
2.195		HIGH:
2.255		ASK:
0.000		VOLUME:
0
CHG(%):
0.23		PREV:
2.210		LOW:
2.180		BID:
0.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
03 Sep 262.1952.2552.1802.2050
02 Sep 262.1952.2902.1952.2100
31 Aug 262.1452.2202.1452.2100
28 Aug 262.1902.2152.1802.1950
27 Aug 262.0902.2452.0902.2300
26 Aug 262.0202.1002.0202.1000
25 Aug 262.0302.0552.0302.0450
24 Aug 261.9982.0451.9762.0450
21 Aug 261.9962.0651.9962.0150
20 Aug 261.9742.0151.9742.0150

PROFILE

Name:PROTALIX BIOTHERAP.DL-01
About:Protalix BioTherapeutics, Inc., a biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on the ProCellEx plant cell-based protein expression system. The company offers Elelyso for the treatment of Gaucher disease; and Elfabrio for the treatment of adult patients with a confirmed diagnosis of Fabry disease. It is also developing PRX-115, a plant cell expressed recombinant PEGylated Uricase, which is in Phase 2 trial for the treatment of gout; and PRX-119, a plant cell expressed PEGylated recombinant human DNase I product candidate for the treatment of neutrophil extracellular traps diseases. The company has agreements and partnerships with Pfizer; Fundação Oswaldo Cruz; and Chiesi Farmaceutici S.p.A. It operates in the United States, Australia, Canada, Israel, Brazil, Russia, and Turkey. The company is headquartered in Hackensack. New Jersey.
Sector:Healthcare
Industry:Biotechnology
Address:2 University Plaza, Hackensack, NJ, United States, 07601
Website:https://www.protalix.com
ISIN:US74365A3095
LEI:549300SDVB3GP4XDFM60

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:10.05 
Forward P/E:50.25 
PEG Ratio:-0.02 
Price to Sales:2.01 
Price to Book:2.63 
Profit Margin:0.24 
Operating Margin:0.23 
Return on Assets:0.15 
Return on Equity:0.31 
Revenue:68.88M 
EBITDA:21.24M 
Shares:79.73M 
Market Cap:175.81M 

TECHNICAL INDICATORS

MA5:2.210.2%
MA10:2.133.7%
MA20:2.095.7%
MA50:2.038.4%
MA100:1.9115.5%
MA200:1.8916.4%
STO9:69.09
STO14:77.27
RSI14:68.37 
WPR14:-7.96 
MTM14:0.29
ROC14:0.15 
ATR:0.07 
Week High:2.293.9%
Week Low:2.095.5%
Month High:2.304.3%
Month Low:1.8816.4%
Year High:2.6620.6%
Year Low:1.2970.9%
Volatility:23.36 

RECENT SPLITS

Date Ratio
20 Dec 20191-10